Tandem Diabetes Care Inc SEC filings TNDM
Tandem Diabetes Care Inc has 1,004 filings in SEC EDGAR's recent list, going back to Dec 16, 2016. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 6, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 7, 2026 | — |
| DEF 14A | Proxy statement | Apr 7, 2026 | Dec 31, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 8, 2025 | — |
| DEF 14A | Proxy statement | Apr 8, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 9, 2024 | — |
| DEF 14A | Proxy statement | Apr 9, 2024 | Apr 9, 2024 |
| DEFA14A | Additional proxy material | Apr 12, 2023 | — |
| DEF 14A | Proxy statement | Apr 12, 2023 | — |
| DEF 14A | Proxy statement | Apr 13, 2022 | Apr 13, 2022 |
| DEFA14A | Additional proxy material | Apr 13, 2022 | — |
| PRE 14A | Preliminary proxy statement | Mar 30, 2022 | Mar 30, 2022 |
| DEFA14A | Additional proxy material | Apr 7, 2021 | — |
| DEF 14A | Proxy statement | Apr 7, 2021 | Apr 7, 2021 |
| DEFA14A | Additional proxy material | May 26, 2020 | — |
| DEFA14A | Additional proxy material | May 18, 2020 | — |
| DEFA14A | Additional proxy material | Apr 15, 2020 | — |
| DEF 14A | Proxy statement | Apr 15, 2020 | Mar 31, 2020 |
| DEFA14A | Additional proxy material | Jun 14, 2019 | — |
| DEFA14A | Additional proxy material | Jun 4, 2019 | — |
| DEFA14A | Additional proxy material | May 31, 2019 | — |
| DEFA14A | Additional proxy material | May 23, 2019 | — |
| DEFA14A | Additional proxy material | Apr 11, 2019 | — |
| DEF 14A | Proxy statement | Apr 11, 2019 | May 22, 2019 |
| DEFA14A | Additional proxy material | Jun 4, 2018 | — |
| DEFA14A | Additional proxy material | May 4, 2018 | — |
| DEFA14A | Additional proxy material | May 1, 2018 | — |
| DEF 14A | Proxy statement | Apr 26, 2018 | Jun 14, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 21, 2018 | Jun 14, 2018 |
| DEFA14A | Additional proxy material | Jul 27, 2017 | — |
| DEF 14A | Proxy statement | Jul 27, 2017 | Sep 7, 2017 |
| PRE 14A | Preliminary proxy statement | Jul 10, 2017 | Jul 10, 2017 |
| DEFA14A | Additional proxy material | Apr 6, 2017 | — |
| DEF 14A | Proxy statement | Apr 6, 2017 | May 16, 2017 |
Showing 34 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TNDM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1438133
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.